FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2100309178> ?p ?o ?g. }

• W2100309178 endingPage "2" @default.
• W2100309178 startingPage "2" @default.
• W2100309178 abstract "BACKGROUND: Fluoxetine was the first molecule of a new generation of antidepressants, the Selective Serotonin Re-uptake Inhibitors (SSRIs). It is recurrently the paradigm for the development of any new therapy in the treatment of depression. Many controlled studies and meta-analyses were performed on Fluoxetine, to improve the understanding of its real impact in the psychiatric area. The main objective of this review is to assess the quality and the results reported in the meta-analyses published on Fluoxetine. METHODS: Published articles on Medline, Embase and Cochrane databases reporting meta-analyses were used as data sources for this review.Articles found in the searches were reviewed by 2 independent authors, to assess if these were original meta-analyses. Only data belonging to the most recent and comprehensive meta-analytic studies were included in this review. RESULTS: Data, based on a group of 9087 patients, who were included in 87 different randomized clinical trials, confirms that fluoxetine is safe and effective in the treatment of depression from the first week of therapy. Fluoxetine's main advantage over previously available antidepressants (TCAs) was its favorable safety profile, that reduced the incidence of early drop-outs and improved patient's compliance, associated with a comparable efficacy on depressive symptoms. In these patients, Fluoxetine has proven to be more effective than placebo from the first week of therapy.Fluoxetine has shown to be safe and effective in the elderly population, as well as during pregnancy. Furthermore, it was not associated with an increased risk of suicide in the overall evaluation of controlled clinical trials.The meta-analysis available on the use of Fluoxetine in the treatment of bulimia nervosa shows that the drug is as effective as other agents with fewer patients dropping out of treatment.Fluoxetine has demonstrated to be as effective as chlomipramine in the treatment of Obsessive-Compulsive-Disorder (OCD). CONCLUSION: Fluoxetine can be considered a drug successfully used in several diseases for its favorable safety/efficacy ratio. As the response rate of mentally ill patients is strictly related to each patient's personal characteristics, any new drug in this area, will have to be developed under these considerations." @default.
• W2100309178 created "2016-06-24" @default.
• W2100309178 creator A5038898384 @default.
• W2100309178 creator A5051261665 @default.
• W2100309178 creator A5071598521 @default.
• W2100309178 date "2004-01-01" @default.
• W2100309178 modified "2023-10-17" @default.
• W2100309178 cites W1482204318 @default.
• W2100309178 cites W1494095809 @default.
• W2100309178 cites W1582689699 @default.
• W2100309178 cites W1599003481 @default.
• W2100309178 cites W1713766390 @default.
• W2100309178 cites W1965649135 @default.
• W2100309178 cites W1966560702 @default.
• W2100309178 cites W1970244749 @default.
• W2100309178 cites W1971193690 @default.
• W2100309178 cites W1971916547 @default.
• W2100309178 cites W1979746269 @default.
• W2100309178 cites W1980240716 @default.
• W2100309178 cites W1983734682 @default.
• W2100309178 cites W1989558433 @default.
• W2100309178 cites W1996114361 @default.
• W2100309178 cites W2011481194 @default.
• W2100309178 cites W2013710578 @default.
• W2100309178 cites W2017722502 @default.
• W2100309178 cites W2034112753 @default.
• W2100309178 cites W2061469903 @default.
• W2100309178 cites W2076065290 @default.
• W2100309178 cites W2080402976 @default.
• W2100309178 cites W2089692407 @default.
• W2100309178 cites W2119089847 @default.
• W2100309178 cites W2133593474 @default.
• W2100309178 cites W2142411964 @default.
• W2100309178 cites W2144888981 @default.
• W2100309178 cites W2148671897 @default.
• W2100309178 cites W2153621599 @default.
• W2100309178 cites W2155363339 @default.
• W2100309178 cites W2161001337 @default.
• W2100309178 cites W2269973050 @default.
• W2100309178 cites W2286373450 @default.
• W2100309178 cites W2416720448 @default.
• W2100309178 cites W2418932039 @default.
• W2100309178 cites W2551409154 @default.
• W2100309178 doi "https://doi.org/10.1186/1475-2832-3-2" @default.
• W2100309178 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/356924" @default.
• W2100309178 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14962351" @default.
• W2100309178 hasPublicationYear "2004" @default.
• W2100309178 type Work @default.
• W2100309178 sameAs 2100309178 @default.
• W2100309178 citedByCount "95" @default.
• W2100309178 countsByYear W21003091782012 @default.
• W2100309178 countsByYear W21003091782013 @default.
• W2100309178 countsByYear W21003091782014 @default.
• W2100309178 countsByYear W21003091782015 @default.
• W2100309178 countsByYear W21003091782016 @default.
• W2100309178 countsByYear W21003091782017 @default.
• W2100309178 countsByYear W21003091782018 @default.
• W2100309178 countsByYear W21003091782019 @default.
• W2100309178 countsByYear W21003091782020 @default.
• W2100309178 countsByYear W21003091782021 @default.
• W2100309178 countsByYear W21003091782022 @default.
• W2100309178 countsByYear W21003091782023 @default.
• W2100309178 crossrefType "journal-article" @default.
• W2100309178 hasAuthorship W2100309178A5038898384 @default.
• W2100309178 hasAuthorship W2100309178A5051261665 @default.
• W2100309178 hasAuthorship W2100309178A5071598521 @default.
• W2100309178 hasBestOaLocation W21003091781 @default.
• W2100309178 hasConcept C118552586 @default.
• W2100309178 hasConcept C126322002 @default.
• W2100309178 hasConcept C139719470 @default.
• W2100309178 hasConcept C142724271 @default.
• W2100309178 hasConcept C162324750 @default.
• W2100309178 hasConcept C168563851 @default.
• W2100309178 hasConcept C170493617 @default.
• W2100309178 hasConcept C17744445 @default.
• W2100309178 hasConcept C199539241 @default.
• W2100309178 hasConcept C204787440 @default.
• W2100309178 hasConcept C27081682 @default.
• W2100309178 hasConcept C2775864247 @default.
• W2100309178 hasConcept C2776134451 @default.
• W2100309178 hasConcept C2776867660 @default.
• W2100309178 hasConcept C2779473830 @default.
• W2100309178 hasConcept C2908647359 @default.
• W2100309178 hasConcept C71924100 @default.
• W2100309178 hasConcept C95190672 @default.
• W2100309178 hasConcept C99454951 @default.
• W2100309178 hasConceptScore W2100309178C118552586 @default.
• W2100309178 hasConceptScore W2100309178C126322002 @default.
• W2100309178 hasConceptScore W2100309178C139719470 @default.
• W2100309178 hasConceptScore W2100309178C142724271 @default.
• W2100309178 hasConceptScore W2100309178C162324750 @default.
• W2100309178 hasConceptScore W2100309178C168563851 @default.
• W2100309178 hasConceptScore W2100309178C170493617 @default.
• W2100309178 hasConceptScore W2100309178C17744445 @default.
• W2100309178 hasConceptScore W2100309178C199539241 @default.
• W2100309178 hasConceptScore W2100309178C204787440 @default.
• W2100309178 hasConceptScore W2100309178C27081682 @default.
• W2100309178 hasConceptScore W2100309178C2775864247 @default.

• next